Indication

For the treatment of severe thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo an invasive procedure.

Medicine details

Medicine name:
avatrombopag (Doptelet)
SMC ID:
SMC2296
Pharmaceutical company
Swedish Orphan
BNF chapter
Nutrition and blood
Submission type
Full
Publication due date:
07 December 2020
SMC meeting date:
03 November 2020
Patient group submission deadline:
07 September 2020